A subscription to JoVE is required to view this content. Sign in or start your free trial.
The protocol proposes an innovative approach to cosmetic dermal filling focusing on ultrasound, icing, pressing, auxiliary gestures, and effective withdrawal to reduce the risk of serious complications like vascular occlusion. Despite the general safety of dermal fillers, accidents can still occur because of the inherent risks.
Cosmetic dermal filling represents a significant advance in aesthetic medicine, providing non-invasive treatments with immediate and durable outcomes. Despite the generally safe nature of dermal fillers and avoidable complications with proper technique and planning, they are still risky, with potential complications varying from mild and transient to severe and enduring. This study introduces innovative strategies designed to decrease the risk of serious complications, such as vascular occlusion. These include the use of ultrasound guidance, the application of ice, auxiliary gestures, effective withdrawal, etc. Throughout our research, we observed no severe complications like embolism, skin necrosis, or ocular issues. However, minor complications such as erythema, edema, and bruising were noted. It is important to recognize that while most severe complications can be avoided with meticulous technique and planning, the inherent risk of unexpected outcomes persists in any medical procedure. Our findings suggest that with these innovative strategies, the safety of cosmetic dermal filling can be significantly enhanced, thereby minimizing the risk of severe adverse effects.
The field of cosmetic surgery has witnessed a paradigm shift with the advent of dermal fillers, a development that has significantly altered the approach to aesthetic enhancement1. These non-invasive treatments, designed to combat the signs of aging and fatigue, offer individuals a viable option for rejuvenation, circumventing the need for traditional surgical interventions. The appeal of dermal fillers lies in their ability to deliver immediate, long-lasting results with minimal downtime, a crucial factor that has fueled their popularity among consumers seeking to enhance their appearance safely and effectively<....
This study was carried out in accordance with the clinical ethics committee guidelines of the First Affiliated Hospital of Zhejiang University. Written informed consent was obtained from all participating patients. Sites of dermal filling generally include the tempora, tear trough, nasolabial fold, and chin. Patients with contraindications, like active skin infections, unrealistic expectations, or a history of related allergies, autoimmune diseases, bleeding disorders, and keloid scarring, were excluded.
In the study, 50 patients seeking cosmetic enhancement were selected. The areas treated included temporal depression (5, needles 30 G), tear troughs (19, needles 32 G/ cannulas 30 G), nasolabial folds (22, needles 30 G/ cannulas 27-30 G), cheek depressions (2, cannulas 27-30 G), and chin (2, needles 30 G) (Table 1). A variety of needle and cannula sizes were chosen based on the treatment area and the type of dermal filler used. Deep filling (as support) is usually injected with 30 G needles, while superf.......
Cosmetic dermal filling stands out as a continually evolving and popular field in aesthetic medicine, driven by factors such as its non-invasive nature, immediate results, minimal downtime, and versatile functions in reducing wrinkles and restoring volume1,2. The appeal also lies in its achievement of natural-looking and long-lasting results1. The ongoing and anticipated rise in popularity can be attributed to innovations in filler formula.......
We would like to thank Dr. Tingbo Liang (Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, School of Medicine, Zhejiang University) for helping project this manuscript.
....Name | Company | Catalog Number | Comments |
Hyaluronic Acid | YVOIRE | CFDA(A)20163131804 | Serves as a supporting role; Supplied with the injection needles (30–32 G) |
Hyaluronic Acid | Imeik | (01)08800050200083 | Serves as volume filling; Supplied with the injection needles |
Cannulas | Conpuvon | 20200017 | For volume filling |
Ultrasound | Philips | EPIQ-5/US120C1632 | Detect anatomic variations or remaining fillers from previous treatments |
This article has been published
Video Coming Soon
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved